Daewoong to launch anti-obesity drug "NVU" next week.

Published: 2007-07-24 06:58:00
Updated: 2007-07-24 06:58:00
Daewoong said that the KFDA approved NVU capsule (sibutramine), an anti-obesity drug, on July 16.

Daewoong is planning to market two types of NVU at 8.27mg and 12.55mg from July 23 by placing a marketing campaign under the message of "Make Korea beautiful and brave" to provide more accurate in...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.